Table 3.

Classic psychedelic use, psychological insight, and physical health.

	Healthy BMI		NCD in the past year		N
	aOR (95% CI)	p	aOR (95% CI)	p
Lifetime use	1.06 (0.82–1.37)	0.662	0.89 (0.65–1.23)	0.487	2822
PIQ scale	1.32 (1.07–1.63)	0.009	1.23 (0.95–1.61)	0.115	613
AMP subscale	1.36 (1.10–1.69)	0.004	1.22 (0.93–1.60)	0.144	613
GAP subscale	1.23 (1.01–1.50)	0.043	1.22 (0.95–1.55)	0.120	613

aOR: adjusted odds ratios; BMI, body mass index; GAP, Goals and Adaptive Patterns; PIQ, Psychological Insight Questionnaire. Significant results (p < 0.05) highlighted in bold.

aOR are adjusted for age in years, gender, ethnoracial identity, sexual orientation, educational attainment, annual household income, marital status, self-reported engagement in risky behavior, lifetime use of cocaine, sedatives, pain relievers, marijuana, phencyclidine (PCP), 3,4-methylenedioxymethamphetamine (MDMA/ecstasy), inhalants, smokeless tobacco, pipe tobacco, cigars, and cigarettes daily, and age of first alcohol use. Note: due to empty cells and collinearity in Stata, ethnoracial identity was dropped from regressions with lifetime use and NCD in the past year while educational attainment was dropped from regressions with psychological insight and NCD in the past year.